Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015)

Prestige Consumer Healthcare's (PBH) quarterly Amortizatization of Intangibles came in at $750000.0 in Q1 2015, up 154.24% year-on-year from $295000.0 in Q1 2014, and up 15.56% quarter-over-quarter from $649000.0 in Q4 2014.

Prestige Consumer Healthcare (PBH) Amortizatization of Intangibles (2010 - 2015) Analysis & Trends

Prestige Consumer Healthcare's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $750000.0 for Q1 2015.

  • On a quarterly basis, Amortizatization of Intangibles rose 154.24% year-over-year to $750000.0 in Q1 2015; TTM through Mar 2015 was $2.1 million, a 38.83% decrease from a year earlier, with the FY2015 full-year figure at $2.1 million, down 38.83% from the prior year.
  • Amortizatization of Intangibles rose to $750000.0 in Q1 2015 per PBH's latest filing, from $649000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.1 million in Q4 2012 and bottomed at $144000.0 in Q2 2014.
  • The 5-year median for Amortizatization of Intangibles is $404000.0 (2012), against an average of $669411.8.
  • Across the five-year window, Amortizatization of Intangibles surged 1244.98% in 2012 and slumped 71.99% in 2014, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $229000.0 in 2011, then jumped by 1244.98% to $3.1 million in 2012, then decreased by 24.77% to $2.3 million in 2013, then slumped by 71.99% to $649000.0 in 2014, then rose by 15.56% to $750000.0 in 2015.
  • Per Business Quant, the three latest PBH Amortizatization of Intangibles figures stand at $750000.0 (Q1 2015), $649000.0 (Q4 2014), and $543000.0 (Q3 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Prestige Consumer Healthcare 2.41 Bn 2.35 Bn 157.37 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2015 750,000.00
Mar 31, 2015 750,000.00
Dec 31, 2014 649,000.00
Dec 31, 2014 649,000.00
Sep 30, 2014 543,000.00
Sep 30, 2014 543,000.00
Jun 30, 2014 144,000.00
Jun 30, 2014 144,000.00
Mar 31, 2014 295,000.00
Mar 31, 2014 295,000.00
Dec 31, 2013 2.32 Mn
Dec 31, 2013 2.32 Mn
Sep 30, 2013 453,000.00
Sep 30, 2013 453,000.00
Jun 30, 2013 345,000.00
Jun 30, 2013 345,000.00
Mar 31, 2013 740,000.00
Mar 31, 2013 740,000.00
Dec 31, 2012 3.08 Mn
Dec 31, 2012 3.08 Mn